Showing results (121-130 of 752) with videos related to
Sort By:
Pageof 76
Neuro-Oncology|October 18, 2017
Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant gliomaBenjamin M Ellingson, Patrick Y Wen, Timothy F CloughesyNeurologic Clinics|November 26, 2019
Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization ClassificationK Ina Ly, Patrick Y Wen, Raymond Y HuangInternational Journal of Clinical and Experimental Medicine|March 12, 2011
Crude drugs as anticancer agentsXiaoyang Mou, Santosh Kesari, Patrick Y Wen, et al.Expert Opinion on Investigational Drugs|June 25, 2009
Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectivesDavid P Samuel, Patrick Y Wen, Mark W KieranNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 22, 2017
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical TrialsBenjamin M Ellingson, Patrick Y Wen, Timothy F CloughesyCancer Journal (Sudbury, Mass.)|September 27, 2021
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and ImmunotherapiesBenjamin M Ellingson, Patrick Y Wen, Timothy F CloughesyJournal of Neuro-Oncology|October 8, 2024
Clinical trial design for novel targeted agents in neuro-oncologyMary Jane Lim-Fat, Katrina Roberto, Patrick Y WenExpert Review of Anticancer Therapy|April 27, 2013
Enhancing radiation therapy for patients with glioblastomaBrian M Alexander, Keith L Ligon, Patrick Y WenGlia|February 26, 2011
Signal transduction inhibitors and antiangiogenic therapies for malignant gliomaIngo K Mellinghoff, Andrew B Lassman, Patrick Y WenNeuro-Oncology|October 25, 2014
Targeted molecular therapies against epidermal growth factor receptor: past experiences and challengesDavid A Reardon, Patrick Y Wen, Ingo K MellinghoffPageof 76